Alimera Sciences


Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Employees

51-200

Links


Org chart

David Dyer
Chief Retina Specialist
Laura Cegala Sphr, Gphr
Vice President, Human Capital
Brittany Underhill
Associate Director, Financial Reporting
Riz Siddiqi
Medical Director, UK & Eire
Steve Morris
Vice President , Medical Director Uk, Head Of Medical Affairs Europe
Bill Garner
Executive Director Marketing
Diane Reeves
Business Manager
Sergei Donskihh
European IT Manager
Ben Flagler
Regional Sales Director
Tom Sinnamon
Region Director Of Sales
Catherine Griffiths
Market Access Manager, UK & Ireland
Deirdre O Reilly
Associate Director Corporate Compliance Training
David Gregory
Associate Director Of Data, Analytics And Innovation
Kapil Kumar
Clinical Account Specialist & Field Sales Trainer
Lillian Contreras
Retina Account Manager
Ryan Armstrong
Thought Leader Liason
Scott Campbell
Thought Leader Liaison
Janine Ainslie Harris
Global Creative And Communications Lead
Anastasia Turano
Senior Thought Leader Liaison


Offices